Top 18 Oxular investors
The most complete profiles first. Showing 18 of 18.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner 路 United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Rishabh ChawlaVerified
Venture Capital 路 Belgium
Health CareChemicalLife ScienceInformation Technology (IT)Portfolio: Animab, Aphea.Bio, Precirix, Confo Therapeutics and 10 more
Verified email available
Geert
Venture Capital, Private Equity Firm, Investment Partner 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor 路 Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor 路 Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Christina Takke
Venture Capital, Private Equity Firm 路 Netherlands
Health CareChemicalLife ScienceInformation Technology (IT)Portfolio: Animab, Aphea.Bio, Precirix, Confo Therapeutics and 10 more
Contact details available
Sander van Deventer
Venture Capital 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner 路 Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Willem Broekaert
Venture Capital, Private Equity Firm 路 Belgium
Health CareChemicalLife ScienceInformation Technology (IT)Portfolio: Animab, Aphea.Bio, Precirix, Confo Therapeutics and 10 more
Contact details available
馃И Ward Capoen
Venture Capital, Private Equity Firm 路 Belgium
Health CareChemicalLife ScienceInformation Technology (IT)Portfolio: Animab, Aphea.Bio, Precirix, Confo Therapeutics and 10 more
Contact details available
By investment stage
- Seed7
By location
Related industries
Most-backed portfolio companies
- Santaris Pharma14
- Argos Therapeutics14
- NovoGI14
- Cardoz14
- Enterprise Therapeutics14
- NeRRe Therapeutics14
- Mitralign14
- CoviCept Therapeutics14
- Pulmologix14
- Fovea Pharmaceuticals14
- FlowMedica14
Frequently asked questions
How many Oxular investors are on Angel Roster?
Angel Roster lists 18 Oxular investors. 4 of them (22%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (9) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Oxular investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Oxular investors based?
Most are based in the Netherlands (13), Belgium (3) and the United Kingdom (1).
Which companies have Oxular investors backed?
The most-backed portfolio companies among them are Santaris Pharma (14), Argos Therapeutics (14), NovoGI (14), Cardoz (14) and Enterprise Therapeutics (14).
How do I contact Oxular investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.